This volume examines beliefs about bird flu and the false promotion of vitamin A as a measles prevention. It also covers social media content moderation and the misrepresentation of a study on gender-affirming care. Lastly, it explores when people prefer AI chatbots over humans for health information.
John Galvin knows he needs a colonoscopy. But he’s waiting to schedule the procedure until December, when he turns 65 and qualifies for Medicare. He was already thinking about delaying it — then his monthly Obamacare insurance premium payment tripled this year to $2,460, about a third of his income, he said. And with a…
Ionis Pharmaceuticals plans a 2026 FDA submission for zilganersen as a treatment for Alexander disease, an ultra-rare inherited neurological disorder. The antisense oligonucleotide developer has been moving toward commercializing drugs on its own rather than seeking partners. The post Ionis Pharma’s Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study appeared…
Affordable health care is our love language. Stoke the fire by submitting your sweetest “Health Policy Valentines.” We want to see your clever, heartfelt, or hilarious tributes to the policies that shape health care. An esteemed panel of editors will review entries. We’ll share favorites on our social media channels, and our staff will pick…
Health economics and outcomes research has already started to use AI tools such as large language models (LLM) across a diverse set of study types, including systematic literature reviews (SLR), health economic modelling (HEM) and real-world evidence (RWE). In SLRs, LLMs can assist with abstract and full-text screening, bias assessment, data extraction, and automating meta-analysis…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
This is the question that a recent AJMCcommentary by William Shrank, Ellen Kelsay, and Mark Fendrick aims to answer. When talking about cell and gene therapies, the authors argue that cost sharing is not being used to avoid unnecessary use of low value care, but rather as a form of rationing that creates disparities in…
This interactive tool, updated with 2022 data, helps users understand health care costs vary by family size, income, insurance, and health status. Use the dropdown menus to explore scenarios and trends in household health spending.
Addressing difficult-to-treat diseases and disorders, quickly, safely, and with little to no side effects is a positive boon to our overburdened health system. The post The Same Processes that Make Smartphones a Risk for Young People Must Be Harnessed to Provide Beneficial Digital Medical Treatments For All appeared first on MedCity News.
This slideshow examines how cost and insurance affects people’s access to care, including decisions to forgo or delay needed care and access to a usual source of care.